Pacific Biosciences of Ca... (PACB)
1.34
0.03 (1.90%)
At close: Mar 04, 2025, 10:11 AM
Pacific Biosciences of California Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Cash & Equivalents | 179.91M | 325.09M | 460.73M | 318.81M | 49.1M | 18.84M | 62.87M | 16.77M | 82.27M | 36.45M | 26.36M | 46.54M | 58.87M | 147.65M | 89.23M | 78.46M |
Short-Term Investments | 451.5M | 447.23M | 583.67M | 237.2M | 19.47M | 83.51M | 46.37M | 55.21M | 48.64M | 64.9M | 86.17M | 54.04M | 118.57M | 136.02M | 3.5M | 27.59M |
Long-Term Investments | 12M | 2.92M | 4.59M | 3.5M | 4M | 4.5M | 4.5M | 4.5M | 9.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 3.7M | 10.53M | 1.17M | 879K | 42K | 43K | 45K | 9.81M | 2.52M | 162K | 490K | 354K | 317K | 322K | 211K | 154K |
Receivables | 36.62M | 18.79M | 24.24M | 16.84M | 15.27M | 8.6M | 13.43M | 11.42M | 5.25M | 3.41M | 2.75M | 2.82M | 4.56M | 341K | n/a | n/a |
Inventory | 56.68M | 50.38M | 24.6M | 14.23M | 13.31M | 17.88M | 23.07M | 15.63M | 10.96M | 11.34M | 10.05M | 9.59M | 15.52M | 6.86M | n/a | n/a |
Other Current Assets | 17.34M | 10.59M | 7.89M | 5.71M | 3.37M | 2.83M | 2.25M | 4.98M | 2.07M | 1.67M | 1.14M | 4.01M | 2.09M | 2.23M | 1.01M | 875K |
Total Current Assets | 742.05M | 855M | 1.11B | 354.75M | 81.05M | 131.66M | 101.62M | 109.01M | 110.54M | 117.76M | 126.46M | 115M | 199.6M | 293.11M | 93.75M | 106.93M |
Property-Plant & Equipment | 69.03M | 81.34M | 79.12M | 54.85M | 62.9M | 34.07M | 37.92M | 14.56M | 8.55M | 6.6M | 9.24M | 14.33M | 18.4M | 12.31M | 7.14M | 6.03M |
Goodwill & Intangibles | 919.25M | 820.22M | 820.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1B | 912.09M | 901.24M | 59.23M | 66.94M | 38.62M | 42.47M | 28.87M | 20.57M | 6.76M | 9.73M | 14.68M | 18.71M | 12.63M | 7.35M | 6.18M |
Total Assets | 1.75B | 1.77B | 2.01B | 413.98M | 147.99M | 170.28M | 144.08M | 137.88M | 131.11M | 124.52M | 136.19M | 129.68M | 218.32M | 305.75M | 101.1M | 113.11M |
Account Payables | 15.06M | 12.03M | 11M | 3.58M | 8.37M | 6.74M | 9.09M | 8.36M | 4.75M | 5.61M | 1.72M | 2.99M | 4.74M | 9.52M | 5.78M | 1.84M |
Deferred Revenue | 16.34M | 32.29M | 36.03M | 10.29M | 7.61M | 6.54M | 6.32M | 7.13M | 17.64M | 12.91M | 10.83M | 3.38M | 6.58M | 3.22M | n/a | 1.1M |
Short-Term Debt | 10.08M | 19.61M | 9.32M | 8.66M | 23.55M | n/a | n/a | n/a | n/a | n/a | 210K | 173K | 140K | 220K | n/a | 1.3M |
Other Current Liabilities | 53.54M | 201.19M | 40.41M | 17.54M | 9.63M | 13.61M | 13.22M | 18.29M | 15.79M | 12.97M | 9.8M | 8.2M | 8.76M | 7.88M | 2.64M | 1.56M |
Total Current Liabilities | 95.03M | 76.92M | 83.29M | 36.49M | 21.84M | 20.35M | 22.32M | 33.77M | 21.93M | 31.49M | 22.55M | 14.74M | 19.38M | 20.84M | 8.42M | 4.7M |
Long-Term Debt | 923.85M | 938.25M | 948.34M | 37.67M | 41.96M | 14.66M | 13.63M | 16.11M | 14.95M | 14.12M | 15.75M | 2.61M | 2.79M | 5.85M | n/a | n/a |
Other Long-Term Liabilities | 20.3M | 800K | 170.89M | 752K | n/a | 13.78M | 14.64M | 2.04M | 4.44M | 3.1M | 1.66M | 2.15M | 3.08M | -813K | 269.8M | 201.79M |
Total Long-Term Liabilities | 949.68M | 1.13B | 1.13B | 42M | 71.23M | 35.87M | 35.66M | 19.44M | 35.64M | 38.09M | 44.45M | 5.56M | 7.48M | 5.04M | 269.8M | 201.79M |
Total Liabilities | 1.04B | 1.2B | 1.22B | 78.49M | 93.07M | 56.21M | 57.98M | 53.22M | 57.57M | 69.57M | 67M | 20.3M | 26.85M | 25.88M | 278.22M | 206.5M |
Total Debt | 933.93M | 957.37M | 953.75M | 42M | 61.67M | 14.66M | 13.63M | 16.11M | 14.95M | 14.12M | 15.96M | 2.79M | 2.93M | 3.04M | n/a | 1.3M |
Common Stock | 268K | 227K | 221K | 192K | 153K | 150K | 116K | 93K | 80K | 74K | 684.48M | 645.37M | 55K | 53K | n/a | n/a |
Retained Earnings | -1.84B | -1.53B | -1.22B | -1.04B | -1.07B | -982.11M | -879.73M | -787.54M | -713.17M | -681.47M | -615.31M | -536.02M | -441.56M | -332.17M | -192M | -104.3M |
Comprehensive Income | 219K | -4.76M | -1.09M | 85K | 5K | -36K | -32K | 5K | -7K | 9K | 14K | 30K | 57K | -21K | 1K | 44K |
Shareholders Equity | 701.3M | 562.9M | 790.99M | 335.49M | 54.92M | 114.06M | 86.1M | 84.67M | 73.54M | 54.95M | 69.18M | 109.38M | 191.46M | 279.87M | -177.12M | -93.39M |
Total Investments | 453.93M | 447.23M | 583.67M | 237.2M | 19.47M | 83.51M | 46.37M | 55.21M | 48.64M | 64.9M | 86.17M | 54.04M | 118.57M | 136.02M | 3.5M | 27.59M |